Fukazawa T - Search Results

1

Antitumor effect of novel HSP90 inhibitor NVP-AUY922 against oral squamous cell carcinoma.

Okui T, Shimo T, Hassan NM, Fukazawa T, Kurio N, Takaoka M, Naomoto Y, Sasaki A. Okui T, et al. Among authors: fukazawa t. Anticancer Res. 2011 Apr;31(4):1197-204. Anticancer Res. 2011. PMID: 21508365

2

Development of a novel beta-cell specific promoter system for the identification of insulin-producing cells in in vitro cell cultures.

Fukazawa T, Matsuoka J, Naomoto Y, Nakai T, Durbin ML, Kojima I, Lakey JR, Tanaka N. Fukazawa T, et al. Exp Cell Res. 2006 Oct 15;312(17):3404-12. doi: 10.1016/j.yexcr.2006.07.015. Epub 2006 Jul 28. Exp Cell Res. 2006. PMID: 16934249

3

Pulmonary adenocarcinoma-targeted gene therapy by a cancer- and tissue-specific promoter system.

Fukazawa T, Maeda Y, Durbin ML, Nakai T, Matsuoka J, Tanaka H, Naomoto Y, Tanaka N. Fukazawa T, et al. Mol Cancer Ther. 2007 Jan;6(1):244-52. doi: 10.1158/1535-7163.MCT-06-0408. Mol Cancer Ther. 2007. PMID: 17237283

4

Malignant pleural mesothelioma-targeted CREBBP/EP300 inhibitory protein 1 promoter system for gene therapy and virotherapy.

Fukazawa T, Matsuoka J, Naomoto Y, Maeda Y, Durbin ML, Tanaka N. Fukazawa T, et al. Cancer Res. 2008 Sep 1;68(17):7120-9. doi: 10.1158/0008-5472.CAN-08-0047. Cancer Res. 2008. PMID: 18757427

5

TAE226, a dual inhibitor for FAK and IGF-IR, has inhibitory effects on mTOR signaling in esophageal cancer cells.

Wang ZG, Fukazawa T, Nishikawa T, Watanabe N, Sakurama K, Motoki T, Takaoka M, Hatakeyama S, Omori O, Ohara T, Tanabe S, Fujiwara Y, Shirakawa Y, Yamatsuji T, Tanaka N, Naomoto Y. Wang ZG, et al. Among authors: fukazawa t. Oncol Rep. 2008 Dec;20(6):1473-7. Oncol Rep. 2008. PMID: 19020730

6

Drug-regulatable cancer cell death induced by BID under control of the tissue-specific, lung cancer-targeted TTS promoter system.

Fukazawa T, Maeda Y, Matsuoka J, Tanaka N, Tanaka H, Durbin ML, Naomoto Y. Fukazawa T, et al. Int J Cancer. 2009 Oct 15;125(8):1975-84. doi: 10.1002/ijc.24584. Int J Cancer. 2009. PMID: 19598260 Free article.

7

Focal adhesion kinase as potential target for cancer therapy (Review).

Hao H, Naomoto Y, Bao X, Watanabe N, Sakurama K, Noma K, Motoki T, Tomono Y, Fukazawa T, Shirakawa Y, Yamatsuji T, Matsuoka J, Wang ZG, Takaoka M. Hao H, et al. Among authors: fukazawa t. Oncol Rep. 2009 Nov;22(5):973-9. doi: 10.3892/or_00000524. Oncol Rep. 2009. PMID: 19787209 Review.

8

Adenovirus-mediated cancer gene therapy and virotherapy (Review).

Fukazawa T, Matsuoka J, Yamatsuji T, Maeda Y, Durbin ML, Naomoto Y. Fukazawa T, et al. Int J Mol Med. 2010 Jan;25(1):3-10. Int J Mol Med. 2010. PMID: 19956895 Review.

9

Progress in researches about focal adhesion kinase in gastrointestinal tract.

Hao HF, Naomoto Y, Bao XH, Watanabe N, Sakurama K, Noma K, Tomono Y, Fukazawa T, Shirakawa Y, Yamatsuji T, Matsuoka J, Takaoka M. Hao HF, et al. Among authors: fukazawa t. World J Gastroenterol. 2009 Dec 21;15(47):5916-23. doi: 10.3748/wjg.15.5916. World J Gastroenterol. 2009. PMID: 20014455 Free PMC article. Review.

10

Autophagy: Can it become a potential therapeutic target?

Bao XH, Naomoto Y, Hao HF, Watanabe N, Sakurama K, Noma K, Motoki T, Tomono Y, Fukazawa T, Shirakawa Y, Yamatsuji T, Matsuoka J, Takaoka M. Bao XH, et al. Among authors: fukazawa t. Int J Mol Med. 2010 Apr;25(4):493-503. doi: 10.3892/ijmm_00000369. Int J Mol Med. 2010. PMID: 20198296 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

417 results

Search Page